The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integrated health system for resolving breast cancer screening actions: Multicenter randomized clinical study—Itaberaí randomized trial, ReBEC, RBR-39vm2nd.
 
Ruffo Freitas-Junior
Honoraria - Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Libbs; Lilly (Inst); MSD; MSD/AstraZeneca; Novartis (Inst); zeiss
Consulting or Advisory Role - Gilead Sciences; MSD Oncology; Novartis
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); MSD (Inst); Novartis Biociencias (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daichii Sankyo; Gilead Sciences; Libbs; MSD/AstraZeneca
 
Danielle Cristina Rodrigues
No Relationships to Disclose
 
Rosangela Corrêa
No Relationships to Disclose
 
Douglas da Silva
No Relationships to Disclose
 
Paola Germek
Speakers' Bureau - Exact Sciences (Inst)
 
Luana Martins
No Relationships to Disclose
 
Christina Cavalcante Costa
No Relationships to Disclose
 
Flavia Vidal Cabero
No Relationships to Disclose
 
Priscila Watanabe
Research Funding - Itaberai City hall
 
Leonardo Soares
No Relationships to Disclose